We are interested in development of novel diagnostics for cancer and autoimmune diseases so the results are faster and more accurate.

San Diego, CA
Joined April 2015
PZM Diagnostics retweeted
Original Article: Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis (NHS-Galleri trial) nej.md/4xRZN5L Editorial: A Step in the Search for the Elusive Holy Grail of Early Detection of Cancer nej.md/4cK3UIy #Oncology #Genetics
2
23
6
65
32,222
PZM Diagnostics retweeted
A person's inherited #genetics can strongly influence not only a person's risk of developing #cancer, but also how that cancer progresses, report researchers at @YaleCancer in a new @Nature study: bit.ly/4pJgMDS
1
2
2
1,432
PZM Diagnostics retweeted
Paternal Caffeine Exposure Programs Offspring Stress Vulnerability
1
15
2
47
7,318
PZM Diagnostics retweeted
Omega-3 supplementation may be associated with accelerated cognitive decline in older adults
31
109
48
481
394,960
Talk to $ibrx and see if this qualifies a trial with a prayer !
Former Nebraska Sen. Ben Sasse was told he had months to live after he was diagnosed with pancreatic cancer in December. Sasse credits "providence, prayer, and a miracle drug" with extending his life. Watch Sasse's interview with Scott Pelley, Sunday on 60 Minutes.
491
$ibrx IL15 is a natural product of human body and its use to correct lymphopenia is physiological. Many studies showed lymphopenia is associated with short survival of cancer. It’s reasonable to correct treatment induced lymphopenia without need to show it will prolong survival.
1
2
310
$ibrx just like chemo induced leukopenia and #Neulasta. No need to show Neulasta actually prevent sepsis/severe bacterial infection because of #leukopenia. Similarly no need to show #epogen prolongs survival of anemic patients due to #hypoxia. This is the other side of argument.
1
3
304
If #FDA approved IL15 for treatment of lymphopenia due to 1 condition, then it’s reasonable to use it for lymphopenia in all conditions. One drug for one disease. #epogen for anemia regardless due to chemo, infection or kidney issues. If expanded access, it’s approvable for all.
2
38
$ibrx the value is to treat lymphopenia associated with cancer treatment. There are large data sets showing lymphopenia is associated with shorted survival in various cancers. #FDA wants data to show correcting lymphopenia can prolong survival. NMIPBC is just a rounding error.
2
1
3
305
$ibrx There is only one current trial for expanded access for lymphopenia. It seems $ibrx thinks FDA is wrong on requiring more data in treatment related lymphopenia in all other cancer types, and $ibrx is not willing to provide the data. It’s an interesting, & unique scenario.
2
339
A lot patients with cancer related lymphopenia will benefit from the drug, but the drug is narrowly approved and most patients won’t be able to get it. That’s really the most important issue. $ibrx should address this. To go after other big indications requires more resources.
258
Preterm delivery and placental pathology with clinical and pathogenic implications | medRxiv medrxiv.org/content/10.64898…
40
To do #RCT on every cancer to treat the same lymphopenia is probably unnecessary. What data to obtain depends on discussion with #FDA. $ibrx already has a lot of data on various cancers. When #lung cancer data published, it will add weight to discussion.
1
1
201